Exploring the Potential of Combining Engineered iPSC NK Cells with NK cell Engagers and the Future of Cell Therapies

Time: 1:45 pm
day: Day 2 - Track C - Afternoon


• Advantages of IPSC derived NK products vs NK cell line, donor derived, or cord blood
• Advantages of NK cell therapies over CAR-T cell therapies
• Advantages of TALEN over CRISPR